Sigma Healthcare (ASX:SIG) Receivables Turnover: 2.66 (As of Dec. 2025)


ASX:SIG Sigma Healthcare Ltd ASX:SIG
58 GF Score
Price A$2.92
GF Value A$0.37
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Sigma Healthcare Receivables Turnover?

Sigma Healthcare ASX:SIG +3.55% 58 Receivables Turnover is 2.66 as of Dec. 2025. GuruFocus rates ASX:SIG with a GF Score™ of 58/100 and a GF Value™ of A$0.37 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 116 Medical Distribution companies, Sigma Healthcare ranks better than 62.93% on this metric.

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Sigma Healthcare's Revenue for the six months ended in Dec. 2025 was A$5,294 Mil. Sigma Healthcare's average Accounts Receivable for the six months ended in Dec. 2025 was A$1,461 Mil. Hence, Sigma Healthcare's Receivables Turnover for the six months ended in Dec. 2025 was 3.62.


Sigma Healthcare  (ASX:SIG) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


Sigma Healthcare Receivables Turnover Related Terms


Sigma Healthcare Receivables Turnover Historical Data

* Premium members only.

The historical data trend for Sigma Healthcare's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sigma Healthcare Receivables Turnover Chart

Sigma Healthcare Annual Data
Trend Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25
Receivables Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.11 10.08 10.55 10.72 7.87

Sigma Healthcare Semi-Annual Data
Jan16 Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24 Jul24 Jan25 Dec25
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.12 5.33 4.12 3.97 2.66

ASX:SIG vs MCK, CAH, COR: Receivables Turnover Comparison

For the Medical Distribution subindustry, Sigma Healthcare's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sigma Healthcare Receivables Turnover vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sigma Healthcare's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Sigma Healthcare's Receivables Turnover falls into.


ASX:SIG
58GF Score
Sigma Healthcare Ltd ASX:SIG
Receivables Turnover is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sigma Healthcare Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Sigma Healthcare's Receivables Turnover for the fiscal year that ended in Jan. 2025 is calculated as

Receivables Turnover (A: Jan. 2025 )
=Revenue / Average Accounts Receivable
=Revenue (A: Jan. 2025 ) / ((Accounts Receivable (A: Jan. 2024 ) + Accounts Receivable (A: Jan. 2025 )) / count )
=4852.324 / ((304.181 + 929.193) / 2 )
=4852.324 / 616.687
=7.87

Sigma Healthcare's Receivables Turnover for the quarter that ended in Dec. 2025 is calculated as

Receivables Turnover (Q: Dec. 2025 )
=Revenue / Average Accounts Receivable
=Revenue (Q: Dec. 2025 ) / ((Accounts Receivable (Q: Jan. 2025 ) + Accounts Receivable (Q: Dec. 2025 )) / count )
=5294.32 / ((929.193 + 1991.868) / 2 )
=5294.32 / 1460.5305
=3.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Receivables Turnover →
What does a Receivables Turnover of 2.66 mean?
Sigma Healthcare (ASX:SIG) has a Receivables Turnover of 2.66 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Sigma Healthcare and its competitors. According to the industry distribution chart, Sigma Healthcare ranks #43 out of 116 companies in the Medical Distribution industry, placing it in the top 37.1%.
Is Sigma Healthcare's Receivables Turnover too high?
Sigma Healthcare's current Receivables Turnover is 2.66. The Medical Distribution industry median Receivables Turnover is 4.55. Sigma Healthcare's value of 2.66 is 41.5% below this industry median. Based on the distribution chart, Sigma Healthcare ranks #43 out of 116 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Sigma Healthcare has a GF Score™ of 58/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sigma Healthcare's Receivables Turnover compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Sigma Healthcare ranks #43 out of 116 companies for Receivables Turnover. This puts Sigma Healthcare in the upper half of its industry. The industry median Receivables Turnover is 4.55. Sigma Healthcare's value of 2.66 is 41.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Distribution company?
The median Receivables Turnover among Medical Distribution companies is 4.55, based on 116 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sigma Healthcare's current Receivables Turnover of 2.66 is 41.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Sigma Healthcare and its competitors. For the Medical Distribution industry, the median Receivables Turnover is 4.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sigma Healthcare's current Receivables Turnover is 2.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sigma Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Sigma Healthcare (ASX:SIG) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.37, compared to a current price of A$2.92 — trading 689.2% above its estimated fair value. The current Receivables Turnover is 2.66 and 41.5% below the Medical Distribution industry median of 4.55. Sigma Healthcare's overall GF Score™ is 58/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Sigma Healthcare (ASX:SIG), the current Receivables Turnover is 2.66 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sigma Healthcare (ASX:SIG) Overvalued in 2026?

Based on GuruFocus' analysis, Sigma Healthcare stock appears to be overvalued. The current stock price of A$2.92 is trading 689.2% above its estimated GF Value™ of A$0.37. GuruFocus considers Sigma Healthcare to be Significantly Overvalued.

Key valuation signals for ASX:SIG:

  • Receivables Turnover: 2.66
  • GF Value™: A$0.37 vs. price of A$2.92 (689.2% above fair value)
  • GF Score™: 58/100 with 8 warning signs
  • Industry Position: 41.5% below the Medical Distribution median (#43 of 116)

No single metric tells the full story. See the ASX:SIG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sigma Healthcare Business Description

Other Exchanges SIGGF:USA
Address 6 Albert Street, Preston, VIC, AUS, 3072
Sigma Healthcare is Australia's largest retail pharmacy franchisor, most notably owning the Chemist Warehouse brand, which it merged with in 2025. Sigma is also Australia's largest full-line wholesaler to franchised and independent pharmacies and distributes a broad range of pharmacy products, including prescription medicines, over-the-counter products, and front of store, or FOS, products, at low prices. The group also operates in New Zealand, Ireland, China, and Dubai, has a growing private label range, and offers third-party logistics services.
58GF Score

Get the complete analysis for ASX:SIG

Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$2.92
Price
A$0.37
GF Value